Upregulated Nmnat2 causes neuronal death and increases seizure susceptibility in temporal lobe epilepsy
•Elevated Nmnat2 causes damage to CA1 neurons and lowers the onset threshold.•Elevated Nmnat2 reduces the expression levels of anti-oxidative proteins.•Molecular chaperone function is involved in the damage mediated by Nmnat2.•Abnormally expressed Nmnat2 affects the activation of signal pathways rel...
Gespeichert in:
Veröffentlicht in: | Brain research bulletin 2021-02, Vol.167, p.1-10 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Elevated Nmnat2 causes damage to CA1 neurons and lowers the onset threshold.•Elevated Nmnat2 reduces the expression levels of anti-oxidative proteins.•Molecular chaperone function is involved in the damage mediated by Nmnat2.•Abnormally expressed Nmnat2 affects the activation of signal pathways related to cell survival.
A significant pathological feature of refractory temporal lobe epilepsy (TLE) is neuronal loss. Oxidative stress caused by repeated seizures is an important mechanism leading to neuronal loss in hippocampus. Nicotinamide-adenine dinucleotide (NAD) a coenzyme that is involved in many biochemical oxidation-reduction reactions. Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) catalyzes an essential step in NAD (NADP) biosynthetic pathwayhas and been considered as a neuronal maintenance factor that protect neurons against insults through context-dependent mechanism. However, it is unexpected that Nmnat2 does not play a neuroprotective role in epilepsy. We found that Nmnat2 was increased in mice model of TLE. Gain-of-function approach revealed that overexpression of Nmnat2 in CA1 area enhanced seizure susceptibility and caused neuronal loss in vivo. Moreover, we found that the chaperone function was essential to increased apoptosis through the function mutation of Nmnat2. Finally, Nmnat2 overexpression in vivo reduced in expression of SOD2 and increased FoxO3a. Overall, our study discloses a new biological function of Nmnat2 in epilepsy and provides novel insights into the molecular events underlying epilepsy. |
---|---|
ISSN: | 0361-9230 1873-2747 |
DOI: | 10.1016/j.brainresbull.2020.11.019 |